C83.78
Burkitt lymphoma, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Burkitt lymphoma is a fast-growing type of non-Hodgkin lymphoma that affects lymphatic system components, primarily lymph nodes. The specific code C83.78 refers to cases where multiple lymph node sites are involved. This aggressive cancer often requires prompt diagnosis and treatment to manage its rapid progression. Despite its seriousness, early detection can significantly improve outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal cell growth Infections such as the Epstein-Barr virus (EBV) Immune system deficiencies Environmental factors, although less common
Key Symptoms: Swelling or lumps in multiple lymph nodes, often painless Unexplained weight loss Fever that persists or recurs Night sweats Fatigue and weakness Abdominal pain or swelling if nearby organs are affected Loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosing Burkitt lymphoma involves a combination of medical history assessment, physical examination, and various medical tests, including: - Imaging studies such as CT scans or PET scans to identify affected areas - Biopsy of affected lymph nodes to examine tissue under a microscope - Blood tests to evaluate overall health and organ function - Bone marrow biopsy if necessary to determine the extent of spread Pathologists look for characteristic features of Burkitt lymphoma, including high-grade cell appearance and specific genetic markers associated with the disease.
Treatment Protocols: The main treatment approaches for Burkitt lymphoma typically include: - Intensive chemotherapy regimens tailored to the patient's overall health and extent of disease - Targeted therapies that attack specific molecules involved in cancer cell growth - Supportive care to manage side effects and complications - In some cases, radiation therapy may be used to target specific areas Early and aggressive treatment is crucial due to the rapid growth of this lymphoma. Multidisciplinary team management often includes hematologists, oncologists, and supportive care specialists to optimize outcomes.
Clinical Advice & FAQs
Billing Guidance
Is C83.78 a billable ICD-10 code?
Yes, C83.78 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.78?
Clinical documentation must specify the nature of Burkitt lymphoma, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference